Abby Levitz
Family · Lagrange, INNPI 1083918833
Payments from drug & device makers
Across 122 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$603
- Axsome Therapeutics, Inc.$191
- Lilly USA, LLC$169
- Xeris Pharmaceuticals, Inc.$138
- AbbVie$138
- Pfizer$131
- plus $695 from 14 others
What the payments were for
- Food & beverage$2,064100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 35 | $603 |
| Axsome Therapeutics, Inc. | 10 | $191 |
| Lilly USA, LLC | 11 | $169 |
| Xeris Pharmaceuticals, Inc. | 8 | $138 |
| AbbVie | 8 | $138 |
| Pfizer | 7 | $131 |
| Adlon Therapeutics L.p. | 9 | $116 |
| Boehringer Ingelheim | 5 | $99 |
| Novo Nordisk | 4 | $83 |
| Novartis | 5 | $79 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $72 |
| Amgen | 4 | $59 |
| Abbott | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| GSK | 2 | $28 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Bayer | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
| Bausch Health US, LLC | 1 | $12 |
How this compares
$2,064 in reported general payments places this provider in the 80th percentile of 4,392 family providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 26 | $19,373 |
| MyrbetriqMirabegron | 21 | $13,035 |
| SavellaMilnacipran Hcl | 13 | $6,355 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 13 | $6,225 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 14 | $4,594 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 22 | $3,208 |
| Vilazodone Hcl | 13 | $1,328 |
| Omeprazole | 69 | $766 |
| Fluticasone Propionate | 41 | $720 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $610 |
| Levothyroxine Sodium | 69 | $532 |
| Potassium Chloride | 27 | $451 |
| Atorvastatin Calcium | 83 | $376 |
| Losartan Potassium | 66 | $366 |
| Lisinopril | 76 | $323 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $99 | $19,37326 claims |
| AbbVieSavella | $138 | $6,35513 claims |
| GSKAnoro Ellipta | $28 | $6,22513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,392 family providers in Indiana.
Other family in Lagrange
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.